NT5DC3 and colonic neoplasm: Later, the particular phosphorylation sites of the NT5DC3 protein regulated by LF were screened by High-Performance Liquid Chromatography (HPLC) and validated by mutation experiments, further confirming that LF suppressed the malignant development from T2D to colon cancer by activating NT5DC3 phosphorylation modifications.